139 related articles for article (PubMed ID: 12926070)
1. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.
Pisani T; Pantellini F; Centanni M; Vecchione A; Giovagnoli MR
Anticancer Res; 2003; 23(4):3323-6. PubMed ID: 12926070
[TBL] [Abstract][Full Text] [Related]
2. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
3. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
5. E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors.
Volante M; Croce S; Pecchioni C; Papotti M
Mod Pathol; 2002 Oct; 15(10):1038-43. PubMed ID: 12379749
[TBL] [Abstract][Full Text] [Related]
6. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
7. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
Renshaw AA
Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
[TBL] [Abstract][Full Text] [Related]
8. Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions.
Midulla C; Pisani T; De Iorio P; Cenci M; Divizia E; Nofroni I; Vecchione A
Anticancer Res; 2002; 22(2B):1341-5. PubMed ID: 12168948
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
Wu HH; Clouse J; Ren R
Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
[TBL] [Abstract][Full Text] [Related]
10. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
Kauffmann PR; Dejax C; de Latour M; Dauplat J
Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology of unsuspected metastatic hurthle cell carcinoma of the thyroid and its pitfalls: a report of two cases.
Lallu S; Naran S; Bethwaite P
Diagn Cytopathol; 2007 Jul; 35(7):439-43. PubMed ID: 17580356
[TBL] [Abstract][Full Text] [Related]
14. Cytology of Hürthle cell neoplasms of thyroid gland.
Hemachandran M; Rajwanshi A; Srinivasan R; Nijhawan R; Radotra BD
Indian J Pathol Microbiol; 2007 Oct; 50(4):859-61. PubMed ID: 18306589
[TBL] [Abstract][Full Text] [Related]
15. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell adenoma of the thyroid: in 32 consecutive cases.
Guadagni S; Francavilla S; Agnifili A; De Bernardinis G; Mariani G; Carboni M
J R Coll Surg Edinb; 1996 Aug; 41(4):246-9. PubMed ID: 8772075
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
[TBL] [Abstract][Full Text] [Related]
19. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
20. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
